CODEXIS TO ESTABLISH NEW R&D FACILITY IN SINGAPORE TO SUPPORT EXPANDING GENERICS BUSINESS

Codexis announced that it will establish a research and development center in Singapore, scheduled to open in the third quarter of 2007. The R&D center will focus on new product development for the company's API and generics business. When fully staffed, the center is expected to house up to 80 R&D and operations personnel. This will be Codexis' second international location, in addition to the company's chemical enzyme and intermediates manufacturing facility in Jlich, Germany. Bionity (http://www.bionity.com/news/e/57348)